Report Detail
Leuprolide Acetate Market By Mode of Administration ( Intramuscular, Subcutaneous ), By Application ( Prostate Cancer, Uterine Fibroid ), By End-use ( Hospitals, Clinics, Medical Institutes ), Industry Trends, Estimation & Forecast, 2017 - 2025
- RnM3857123 |
- 23 December, 2019 |
- Global |
- 150 Pages |
- Esticast Research & Consulting |
- Healthcare
The research report offers a comprehensive picture of the Leuprolide Acetate market. The report initiates with the executive summary of the market that includes market definition, recent industry trends, and developments, strategies of the key players and wide product offerings. Moreover, the study explains the future opportunities and a sketch of the key participants actively operating in the market.
About Leuprolide Acetate Market
Leuprolide acetate is a nonapeptide acetate salt which can be used as a substitute to the gonadotropin-releasing hormone. The leuprolide acetate hormone analogue is used for curing or inhibiting certain diseases prevalent in both men and women. Leupron is the brand name by which leuprolide acetate injections are commercialized throughout the world. The salt has been found highly efficient for certain therapies used for prohibiting the growth of prostate cancer in men. Prostate cancer is highly stimulated by the generation of testosterones in the body. Leupron acts as a LHRH agonist. As per NIH, in 2015, there were an estimated 3,120,176 men living with prostate cancer in the United States. Lupron is also prescribed for the women dealing with endometriosis and Uterine Fibroids, which are one of the most complicated and painful diseases related to female reproductive system.
The research report is prepared based on the combination of qualitative as well as quantitative aspects. By thorough understanding, the report is fragmented by larger ratios. The report covers in-depth analysis with major factors such as drivers, restraints, opportunities, and challenges that influences the growth of the market. On the other hand, The Leuprolide Acetate report presents data starting from the base year 2018, historical year: 2014-2018, estimated the year 2019 and Forecast year from 2019 to 2026.
The Leuprolide Acetate market report offers the market size and estimates the forecast from 2019-2026. The forecast estimation is predicted based on the key regions that include North America, Europe, Asia Pacific, Middle East, South America, and the Middle East & Africa. Furthermore, the Leuprolide Acetate report provides a deep emphasis on secondary tools used to document the report. PEST analysis, SWOT, Porter’s Five Forces, and others are considered by the analysts while preparing the report.
Scope and Segmentation of the Market
Based on Type
Product 1
Product 2
Based on Application
Prostate Cancer
Uterine Fibroid
Others
Each segment of the Leuprolide Acetate market is extensively evaluated in the research study. The segment analysis covered in the report aims at the key opportunities available in the Leuprolide Acetate market report by leading segments. In addition, the research report offers market dynamics for the market that influences qualitative as well as quantitative research.
Research Methodology
The report follows a comprehensive and rigorous research methodology to provide you accurate estimates and forecasts of a particular market. The report provide estimates, forecast, and analysis primarily based on secondary research, primary interviews, in-house database and other free as well as paid sources. In addition, the research methodology we follow is a systematic approach in order to estimate and project the market sizing keeping in mind all the ongoing and upcoming trends of the market.
Competitive Landscape
Key players profiled in this report include (Sales Revenue, Price, Gross Margin, Main Products, etc.):
Sun Pharmaceutical Industries Ltd.
Varian Pharmed
Avenit AG
Takeda Pharmaceutical Company Limited
Livzon Pharmaceutical Group Co. Ltd.
Beijing Biote Pharmaceutical Co. Ltd
Soho-YImIng
AbbVie Inc.
Sanofi
Astellas Pharma
Abbott
Merck KGaA
Pfizer Inc.
Through the successive chapters on the company, profiles provide deep insights on players operating in the Leuprolide Acetate market. It focuses on the financial outlook of the key players, the status of R&D, strategies adopted, expansion strategies, and many more. Analysts preparing the report have offered a detailed list of the strategic initiatives adopted by the Leuprolide Acetate market participants by referring past records and designing strategies to be adopted in the coming years. This enables the key players to stay ahead in the competition.
Regional Landscape
The chapter on regional segmentation details the regional aspects of the Leuprolide Acetate market. This chapter explains the regulatory framework that is likely to impact the overall market. It highlights the political scenario in the market and anticipates its influence on the Leuprolide Acetate market. Moreover, the report focuses on value and volume at the regional level, company level, and level.
Chapters covered under this report include:
Chapter 1, describes the Leuprolide Acetate market reports - market overview, executive summary, and market scope. Further, the report adds a support base to identify the information and pick in relation to the aforementioned market
Chapter 2, defines the research methodology based on primary as well as secondary research, secondary data sources, and assumptions & exclusions
Chapter 3, description of Leuprolide Acetate market in terms of its product scope, opportunities, drivers, restraints, and market risks
Chapter 4, the report offers a company profile of the top manufacturers of Leuprolide Acetate market with its sales, revenue, share, and others
Chapter 5 and 6, to narrow down the sales data at the country level with shares, revenue, sand sales from 2018-2026
Chapter 7, the Leuprolide Acetate market data is published based on a regional level and to show the revenue, sales, and growth on basis of the base year 2018, historical year: 2014-2018, estimated the year 2019 and Forecast year from 2019 to 2026
Chapter 8, describes the Leuprolide Acetate market sales channels, distributors, research findings, appendix, and among others.
CHAPTER 1. INTRODUCTION
- 1.1. RESEARCH METHODOLOGY
- 1.1.1. ERC desk research
- 1.1.2. ERC data synthesis
- 1.1.3. Data validation and market feedback
- 1.1.4. ERC data sources
CHAPTER 2. LEUPROLIDE ACETATE MARKET OVERVIEW
- 2.1. LEUPROLIDE ACETATE MARKET INTRODUCTION
- 2.2. GLOBAL LEUPROLIDE ACETATE MARKET PRODUCTION AND GROWTH RATE, 2017-2025
- 2.2.1. Global Leuprolide Acetate Production (VOLUME) and Growth Rate (%), (2017-2025)
- 2.3. GLOBAL LEUPROLIDE ACETATE MARKET CAPACITY AND GROWTH RATE, 2017-2025
- 2.3.1. Global Leuprolide Acetate Capacity (VOLUME) and Growth Rate (%), (2017-2025)
- 2.4. GLOBAL LEUPROLIDE ACETATE MARKET REVENUE AND GROWTH RATE, 2017-2025
- 2.4.1. Global Leuprolide Acetate Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
- 2.5. GLOBAL LEUPROLIDE ACETATE MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
- 2.5.1. Global Leuprolide Acetate Consumption (VOLUME) and Growth Rate (%), (2017-2025)
- 2.6. GLOBAL LEUPROLIDE ACETATE MARKET PRICE TREND, 2017-2025
- 2.6.1. Global Leuprolide Acetate Market Price Trend and Growth Rate (%), (2017-2025)
CHAPTER 3. GLOBAL LEUPROLIDE ACETATE MARKET BY MODE OF ADMINISTRATION, 2017-2025
- 3.1. INTRAMUSCULAR
- 3.2. SUBCUTANEOUS
- 3.3. GLOBAL LEUPROLIDE ACETATE MARKET REVENUE BY MODE OF ADMINISTRATION, 2017-2025
- 3.3.1. Global Leuprolide Acetate Market Revenue (Million USD) and Share (%) By Mode of Administration, 2017-2025
- 3.3.2. Intramuscular Market Revenue and Growth Rate, 2017-2025
- 3.3.3. Subcutaneous Market Revenue and Growth Rate, 2017-2025
- 3.4. GLOBAL LEUPROLIDE ACETATE MARKET PRODUCTION BY MODE OF ADMINISTRATION, 2017-2025
- 3.4.1. Global Leuprolide Acetate Market Production (Volume) and Share (%) By Mode of Administration, 2017-2025
- 3.4.2. Intramuscular Market Production and Growth Rate, 2017-2025
- 3.4.3. Subcutaneous Market Production and Growth Rate, 2017-2025
CHAPTER 4. GLOBAL LEUPROLIDE ACETATE MARKET BY APPLICATION, 2017-2025
- 4.1. PROSTATE CANCER
- 4.2. UTERINE FIBROID
- 4.3. OTHERS
- 4.4. GLOBAL LEUPROLIDE ACETATE MARKET REVENUE BY APPLICATION, 2017-2025
- 4.4.1. Global Leuprolide Acetate Market Revenue (Million USD) and Share (%) By Application, 2017-2025
- 4.4.2. Prostate Cancer Market Revenue and Growth Rate, 2017-2025
- 4.4.3. Uterine Fibroid Market Revenue and Growth Rate, 2017-2025
- 4.4.4. Others Market Revenue and Growth Rate, 2017-2025
- 4.5. GLOBAL LEUPROLIDE ACETATE MARKET CONSUMPTION BY APPLICATION, 2017-2025
- 4.5.1. Global Leuprolide Acetate Market Consumption (Volume) and share (%) By Application, 2017-2025
- 4.5.2. Prostate Cancer Market Consumption and Growth Rate, 2017-2025
- 4.5.3. Uterine Fibroid Market Consumption and Growth Rate, 2017-2025
- 4.5.4. Others Market Consumption and Growth Rate, 2017-2025
Note: Similar information coverage has been provided for end user segment.
CHAPTER 5. GLOBAL LEUPROLIDE ACETATE MARKET BY REGION, 2017-2025
- 5.1. NORTH AMERICA
- 5.1.1. U.S.
- 5.1.2. Canada
- 5.1.3. Mexico
- 5.2. EUROPE
- 5.2.1. U.K.
- 5.2.2. France
- 5.2.3. Germany
- 5.2.4. Italy
- 5.2.5. Spain
- 5.2.6. Rest of Europe
- 5.3. ASIA PACIFIC
- 5.3.1. China
- 5.3.2. Japan
- 5.3.3. India
- 5.3.4. Korea
- 5.3.5. Rest of APAC
- 5.4. SOUTH AMERICA
- 5.4.1. Brazil
- 5.4.2. Rest of South America
- 5.5. REST OF THE WORLD
- 5.5.1. Middle East
- 5.5.2. Africa
- 5.6. GLOBAL LEUPROLIDE ACETATE MARKET REVENUE BY REGION, 2017-2025
- 5.6.1. Global Leuprolide Acetate Market Revenue (Million USD) and Share (%) By Region, 2017-2025
- 5.6.2. North America Market Revenue and Growth Rate, 2017-2025
- 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
- 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
- 5.6.5. South America Market Revenue and Growth Rate, 2017-2025
- 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025
CHAPTER 6. GLOBAL LEUPROLIDE ACETATE MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
- 6.1. GLOBAL LEUPROLIDE ACETATE MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
- 6.1.1. Global Leuprolide Acetate Market Production (Volume) and Share (%) By Region, 2017-2025
- 6.1.2. Global Leuprolide Acetate Market Consumption (Volume) and Share (%) By Region, 2017-2025
- 6.1.3. North America Market Production and Consumption, 2017-2025
- 6.1.4. Europe Market Production and Consumption, 2017-2025
- 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
- 6.1.6. South America Market Production and Consumption, 2017-2025
- 6.1.7. Rest of the World Market Production and Consumption, 2017-2025
CHAPTER 7. MARKET DETERMINANTS
- 7.1. MARKET DRIVERS
- 7.2. MARKET RESTRAINTS
- 7.3. MARKET OPPORTUNITIES
- 7.4. MARKET DETERMINANTS RADAR CHART
CHAPTER 8. GLOBAL LEUPROLIDE ACETATE MARKET COMPETITION BY MANUFACTURERS
- 8.1. GLOBAL LEUPROLIDE ACETATE PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
- 8.1.1. Global Leuprolide Acetate Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
- 8.2. GLOBAL LEUPROLIDE ACETATE REVENUE AND SHARE BY MANUFACTURERS (2017-2025) 36
- 8.2.1. Global Leuprolide Acetate Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
- 8.3. LEUPROLIDE ACETATE MARKET COMPETITIVE SITUATION AND TRENDS
- 8.3.1. Leuprolide Acetate Market Share (%) of Top 3 Manufacturers
- 8.3.2. Leuprolide Acetate Market Share (%) of Top 5 Manufacturers
CHAPTER 9. GLOBAL LEUPROLIDE ACETATE MANUFACTURERS ANALYSIS
- 9.1. SUN PHARMACEUTICAL INDUSTRIES LTD.
- 9.1.1. Business Overview
- 9.1.2. Company Basic Information
- 9.1.3. Leuprolide Acetate Product Details
- 9.1.4. Sun Pharmaceutical Industries Ltd. Leuprolide Acetate Production, Revenue and Gross Margin
- 9.2. VARIAN PHARMED
- 9.2.1. Business Overview
- 9.2.2. Company Basic Information
- 9.2.3. Leuprolide Acetate Product Details
- 9.2.4. Varian Pharmed Leuprolide Acetate Production, Revenue and Gross Margin
- 9.3. AVENIT AG
- 9.3.1. Business Overview
- 9.3.2. Company Basic Information
- 9.3.3. Leuprolide Acetate Product Details
- 9.3.4. Avenit AG Leuprolide Acetate Production, Revenue and Gross Margin
- 9.4. TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 9.4.1. Business Overview
- 9.4.2. Company Basic Information
- 9.4.3. Leuprolide Acetate Product Details
- 9.4.4. Takeda Pharmaceutical Company Limited Leuprolide Acetate Production, Revenue and Gross Margin
- 9.5. LIVZON PHARMACEUTICAL GROUP CO., LTD.
- 9.5.1. Business Overview
- 9.5.2. Company Basic Information
- 9.5.3. Leuprolide Acetate Product Details
- 9.5.4. Livzon Pharmaceutical Group Co., Ltd. Leuprolide Acetate Production, Revenue and Gross Margin
- 9.6. BEIJING BIOTE PHARMACEUTICAL CO., LTD
- 9.6.1. Business Overview
- 9.6.2. Company Basic Information
- 9.6.3. Leuprolide Acetate Product Details
- 9.6.4. Beijing Biote Pharmaceutical Co., Ltd Leuprolide Acetate Production, Revenue and Gross Margin
- 9.7. SOHO-YIMING
- 9.7.1. Business Overview
- 9.7.2. Company Basic Information
- 9.7.3. Leuprolide Acetate Product Details
- 9.7.4. Soho-YImIng Leuprolide Acetate Production, Revenue and Gross Margin
- 9.8. ABBVIE INC.
- 9.8.1. Business Overview
- 9.8.2. Company Basic Information
- 9.8.3. Leuprolide Acetate Product Details
- 9.8.4. AbbVie Inc. Leuprolide Acetate Production, Revenue and Gross Margin
- 9.9. SANOFI
- 9.9.1. Business Overview
- 9.9.2. Company Basic Information
- 9.9.3. Leuprolide Acetate Product Details
- 9.9.4. Sanofi Leuprolide Acetate Production, Revenue and Gross Margin
- 9.10. ASTELLAS PHARMA
- 9.10.1. Business Overview
- 9.10.2. Company Basic Information
- 9.10.3. Leuprolide Acetate Product Details
- 9.10.4. Astellas Pharma Leuprolide Acetate Production, Revenue and Gross Margin
CHAPTER 10. LEUPROLIDE ACETATE MARKET VALUE CHAIN ANALYSIS
- 10.1. LEUPROLIDE ACETATE INDUSTRIAL CHAIN ANALYSIS
- 10.2. LEUPROLIDE ACETATE KEY RAW MATERIALS ANALYSIS
- 10.2.1. Key Raw Materials
- 10.2.2. Price Trend of Key Raw Materials
- 10.2.3. Key Suppliers of Raw Materials
- 10.3. MARKETING CHANNEL
- 10.3.1. Direct Marketing
- 10.3.2. Indirect Marketing
- 10.3.3. Distributors/Traders
- 10.4. CONSUMER ANALYSIS
- 10.4.1. Consumer 1
- 10.4.2. Consumer 2
- 10.4.3. Consumer 3
Summary:
Get latest Market Research Reports on Leuprolide Acetate . Industry analysis & Market Report on Leuprolide Acetate is a syndicated market report, published as Leuprolide Acetate Market By Mode of Administration ( Intramuscular, Subcutaneous ), By Application ( Prostate Cancer, Uterine Fibroid ), By End-use ( Hospitals, Clinics, Medical Institutes ), Industry Trends, Estimation & Forecast, 2017 - 2025. It is complete Research Study and Industry Analysis of Leuprolide Acetate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
